ProJect Pharmaceutics enters collaboration with German CMO as the preferred development partner for lyophilization

ProJect Pharmaceutics is a contract research and development organization (CRO) specialized in formulation and process development for parenteral drug products. Adjacent to its service portfolio, ProJect Pharmaceutics operates a broad network towards contract manufacturing organizations (CMOs) for drug substance and drug product to support its clients towards selecting the best fit for their products’ manufacturing requirements.

As state-of-the-art development experts ProJect Pharmaceutics is teamed up with state-of-the-art manufacturing experts at LYOCONTRACT GmbH to provide high-quality parenterals from pre-clinical to clinical and large commercial scale.

ProJect Pharmaceutics’ clients can profit from a direct line to a) liquid fill & finish services on a modern filling line, and b) manufacturing of lyophilized products for clinic and market supply on high-class commercial lyophilization plants.

The CMO’s clients can profit from a direct line to lyophilization cycle development and/or optimization towards a robust but efficient lyo cycle design – an efficient lyo cycle can not only safe our clients time and thus pure money on manufacturing batches, but also facilitate to get a manufacturing slot way easier at CMOs by not blocking the manufacturing line for days or weeks